We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.25 | 3.20 | 3.30 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.24 | 2.93M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/6/2022 12:24 | VAL, like DDDD, has been afflicted by 'The curse of Porky'. Apologies for the levity, and my sympathy for those still invested. | 801710245 | |
30/6/2022 12:01 | What discount the share price was over 50p wasn't it??? | tonythemanwithnoname | |
30/6/2022 11:59 | This reminds me when GM was in charge what BS did he speak.. ValiRx PLC ("ValiRx" or the "Company") Placing of 15,000,000 Ordinary Shares at issue price of 10p per share Proposed Broker Option for up to 10,000,000 Ordinary Shares at the Issue Price London, UK - ValiRx Plc (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and women's health, announces a Placing to raise GBP1.5 million (before expenses) through the allotment and issue of 15,000,000 New Ordinary Shares at the Issue Price of 10 pence per Ordinary Share. In addition, to provide shareholders and other investors who did not initially have the opportunity to participate in the Placing to now do so, the Company is granting an option (the "Broker Option") allowing additional subscriptions up to GBP1.0 million with priority given to existing shareholders of the Company. The net proceeds from the Fundraising will be used to provide working capital for the Group to continue development of its assets, as well as strengthen its balance sheet with a view to pursuing its acquisitive tCRO strategy. Fundraising highlights -- Placing to raise GBP1.5 million from new and existing shareholders to provide working capital for the Group and strengthen its balance sheet to progress the Company's acquisitive tCRO (Translational Contract Research Organisation) model -- Conditional Broker Option to provide shareholders and other investors who did not initially have the opportunity to participate in the Placing to participate in the Fundraise for up to GBP1.0 million -- Issue Price of 10p per share represents a discount of 38% to closing market price on last practicable Business Day prior to this announcement | tonythemanwithnoname | |
30/6/2022 11:56 | It was undervalued @1p....lol | tonythemanwithnoname | |
30/6/2022 11:55 | Down 33% on the day... | tonythemanwithnoname | |
30/6/2022 11:54 | Oh dear the morons are back. It's not over till the fat lady sings. It's called an investment. I was never in it for five minutes. Let's see where we are in two/three years time. I'm confident this share will pay off handsomely. Good luck LTH | sooty snipes | |
30/6/2022 11:48 | 🤡🫱 6p | average down mug | |
30/6/2022 11:48 | 🤡🫱 6p | average down mug | |
30/6/2022 11:38 | "livedata21 - 24 Jun 2022 - 20:09:17 - 7393 of 7700 4D Pharma Research Thread - DDDD Glad I’m invested in Valirx (val) and not DDDD. Good luck all" What goes around...... | david gruen | |
30/6/2022 11:38 | She's hanged herself to me because of her tweets and over confident style. Outrageous, she sucked a lot of investors to top up or buy into VAL making out TRX was a done deal by end of June | sooty snipes | |
30/6/2022 11:36 | Any company that needs money in this market will get hammered - At least the placing here is at 10p - | tomboyb | |
30/6/2022 11:33 | Reference Suzy. I think most of us agree she isn't CEO material. | sooty snipes | |
30/6/2022 11:29 | Definitely.... She should go with immediate effect. | ben gibbons | |
30/6/2022 11:27 | How do you get in at 10p if there are shares not subscribed for? | tburns | |
30/6/2022 11:26 | I spoke with her in mid December and she said she was still hopeful it would be done by the end of December as the yanks didn’t have as many holidays as we do in the U.K. over Christmas. Go figure - out of her depth . | francoismyname | |
30/6/2022 11:24 | I'd be interested in getting Adam Hargreaves view. After all it is his line of business | sooty snipes | |
30/6/2022 11:21 | Suzy should resign. Flat out mislead investors! | ben gibbons | |
30/6/2022 11:17 | Average is 22p. Not impressed with Suzy Dilly's tweets. Reckless and unprofessional. Funding was always on the cards once TRX funding wasn't forthcoming. TRX should have been sacked off months ago. Surprised funding at10p is so low. Needless she could have raised months ago when we stood at 30-40p. | sooty snipes | |
30/6/2022 11:12 | How long have you held here sooty ? | arab3 | |
30/6/2022 11:11 | Wish I had now at 50,40,30,20p | francoismyname | |
30/6/2022 11:09 | If you think that just sell up and move on. | sooty snipes | |
30/6/2022 10:54 | It was fill your boots time at 50,40,30,20p Nothing ever changes here. Company been going 15 years or so and never delivered a business deal with any income. Quite staggering really. It’s a charity to fund the BOD. | francoismyname | |
30/6/2022 10:52 | Wonder what Adam thinks of all this? | sooty snipes | |
30/6/2022 10:47 | The placing was always on the cards. At 10p fill your boots! | sooty snipes |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions